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Abstract
Background: Secondary dengue causes more severe disease than the primary. Early on, it is important to
differentiate the two. We tried to find important clinical and laboratory differences between the two for the
purpose of early differentiation.
Methods: One hundred fourteen patients confirmed on reverse transcriptase-polymerase chain reaction (RT PCR)
were studied. On day 2 of illness IgM and IgG indices were studied for calculation of IgG/IgM ratio. A one-step
immunochromatographic assay was used for classification of patients into primary and secondary dengue. Patient
characteristics were also studied.
Results: Dengue serotype 1 was the most common found in 60.5% patients. 66.7% (76 patients) had secondary
dengue. Secondary dengue cases had a higher mean temperature (101.56 ± 1.55 vs. 100.79 ± 1.25,°F, p 0.015), lower
platelet counts (50.51 ± 38.91 vs. 100.45 ± 38.66, x 103/micl, p <0.0001) and a significantly higher percentage of
Dengue hemorrhagic fever/Dengue shock syndrome (38.2% vs. 2.6%, p <0.0001). In early phase of dengue NS1 and
PCR were found to be better tests for diagnosis and later IgM is better. The IgG/IgM ratio of≥ 1.10 had a sensitivity
of 100%, specificity of 97.4% and accuracy of 67.5% in differentiating secondary from primary dengue.
Conclusion: Early on in the clinical course, IgG/ IgM ratio can play an important role to differentiate the two. We
found the ratio of≥ 1.10 to be the best cut off for the same.
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Background
Summary
Dengue is a viral disease that is transmitted by mosquitoes
in tropical areas. India is one of the countries maximally af-
fected by it. Dengue can either cause a self limiting fever
with low platelets or a severe disease characterized by
capillary leak, intravascular volume depletion, severely low
platelet counts and a high grade fever. There are 4 distinct
types of dengue viruses known to cause dengue. Infection
with a particular kind of dengue virus builds lifelong
immunity to it, but the person is still vulnerable to be
infected with the other types of dengue viruses. Infection
with other kinds of dengue viruses in a person who already
had a dengue fever in the past is called secondary dengue
and has been found to be severe. This is due to more se-
vere immunological response in the body [1]. In our study
we found that secondary dengue caused more severe dis-
ease features like shock, low platelets and higher grade
fever. We tried ELISA based tests to differentiate second-
ary dengue as they are cheaper and more easily available in
resource poor countries which bear the brunt of the dis-
ease. IgG/IgM ratio of >1.10 is useful for diagnosis of sec-
ondary dengue early on in the illness when it is very
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difficult to predict which patients have secondary dengue
using other features.
Introduction
Dengue fever (DF) is a serious illness in many tropical and
subtropical countries. In ancient Chinese literature it has
been referred to as “water poison” due to its association with
flying insects. The etiological organisms responsible are den-
gue viruses (DENV) belonging to the family Flaviviridae,
genus Flavivirus. Dengue virus has 4 serotypes : 1,2,3,4. The
WHO 2009 classification divides dengue depending on the
severity of illness. It classifies dengue as with or without
warning signs (pain abdomen, severe vomiting, fluid reten-
tion and third spacing, mucosal hemorrhage, malaise and
drowsiness, hepatomegaly, high hematocrit with low plate-
lets); and severe dengue (severe plasma leakage, severe
bleeding, or organ failure) [2]. On the other hand 1997 clas-
sification divides it into undifferentiated fever, dengue fever
(DF), and dengue haemorrhagic fever (DHF) [3]. We chose
the latter definition in our study to allow for comparison
with previous studies most of which have used the same
definition. In India, Dengue has been known since 1946 and
has been present in different parts of the country as epi-
demics and outbreaks. In 1960s it had established its en-
demicity in India and different strains have been replacing
the older ones ever since [4]. Asymptomatic infections are
much more frequent than symptomatic ones [5]. Severe
DENV infection like dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS) are chiefly seen with second-
ary infection [6, 7]. Considering this, it becomes very im-
portant to distinguish primary from secondary dengue early
on in the course of illness. It helps in predicting prognosis
and also in deciding about whether a patient needs admis-
sion and close monitoring or could be managed at home.
This becomes more important during epidemics and out-
breaks when hospitals are flooded with patients and early
triage becomes necessary.
The Hemagglutination inhibition (HI) test was the stand-
ard reference test recommended by the World Health
Organization (WHO) to classify primary and secondary den-
gue virus infection [8]. This reference test requires paired
serum samples and cannot give an early diagnosis, exhibits
high cross-reactivity and requires chemical pre-treatment to
remove nonspecific inhibitors of hemagglutination [9, 10].
So, researchers have tried to find out better and easier
methods to differentiate primary from secondary dengue.
IgG avidity can be used to discriminate among primary den-
gue and secondary dengue infection [11].
The aim of this study is to differentiate primary from
secondary dengue using IgG to IgM ratio from enzyme-
linked immunosorbent assays (ELISA) based detection
of specific antibodies. The IgG and IgM ELISA has the
benefit of easier use, being suitable for surveillance and
for large-scale studies. Several studies have been
performed to discriminate primary and secondary DENV
infection using the ratio of IgG and IgM at the different
days of onset of symptoms [12–16]. We look for the best
IgG/IgM ratio to differentiate primary and secondary
DENV infection in our population within the first three
days of symptom onset.
Methods
This study was conducted in two tertiary care hospitals in
the National Capital Region of India. It was a prospective
observational study done from July to December 2015
when the maximum numbers of dengue cases are
recorded. Patients with suspected dengue fever who
presented within 2 days of symptom onset were recruited
in the study with proper informed consent. Two hundred
twenty-five patients with suspected dengue were initially
recruited in the study. Of these only those who tested
positive for dengue on reverse transcriptase polymerase
chain reaction (RT PCR) [SimplexaTM Dengue RT-PCR,
focus diagnostics] testing were studied further. Thus only
114 patients were studied further. Patients were studied
for clinical, laboratory and serological patterns.
Qualitative detection of NS-1, IgM and IgG
The SD BIOLINE Dengue Duo rapid test kit produced by
Standard Diagnostics was used for classification of pa-
tients into primary and secondary dengue. It is a one-step
immunochromatographic assay designed for the detection
of both dengue virus NS1 antigen and differential IgM/
IgG antibodies to dengue virus in whole blood, serum, or
plasma. For SD BIOLINE dengue NS1 Ag device, 100 μL
of the test sample was added into the sample well (S). Test
results were interpreted at 15–20 min. Similarly, for SD
BIOLINE dengue IgG/IgM device, 10 μL of test sample
was added into the sample well (S). This was followed by
the addition of 4 drops (90–120 μL) of assay diluent to the
round shaped assay diluent well. Results were interpreted
at 15–20 min. The test results were examined and
interpreted according to the manufacturer instructions by
three different readers to avoid biasness.
Case definition of primary and secondary dengue
Primary infection was defined as an IgM-negative/IgG-
negative; or IgM-positive/IgG-negative on the blood sample
drawn within 3 days of symptom onset. Secondary infection
was defined as an IgM-negative/IgG-positive or an IgM-
positive/IgG-positive result on the blood sample drawn
within 3 days of symptom onset. We could not differentiate
secondary from tertiary or quarternary dengue so some pa-
tients classified as having secondary dengue could have had
tertiary or quarternary dengue. Days of illness were calcu-
lated considering the day of onset of symptoms (like fever,
body aches, vomiting etc.) as the first day. The sensitivity
and specificity of the use of SD BIOLINE Dengue Duo
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rapid test kit to classify dengue cases into primary and sec-
ondary dengue infection is 94.2 and 96.4% respectively [17].
Another blood sample was drawn on day 7 after symp-
tom onset for IgM to detect the rise in the IgM positive
patients tested on the SD BIOLINE Dengue Duo rapid
test kit.
DENV IgM and IgG index measurement
The Focus Diagnostics Dengue Virus IgM and IgG Capture
DxSelectTM were used. Both are Indirect Enzyme-linked
immunosorbent assay (ELISA) tests. The IgM assay uses a
flavivirus group monoclonal horseradish peroxidase conju-
gate with TMB as substrate. Each Capture Well is coated
with antihuman IgM. The antigen solution contains equal
proportions of inactivated DV types 1–4. The polystyrene
microwells are coated with anti-human antibody specific
for IgM (μ -chain). Diluted serum samples and controls are
incubated in the wells, and IgM present in the sample binds
to the anti-human antibody (IgM specific) in the wells.
Dengue virus (DV) antigen is then added to the wells and
incubated; and, if anti-DV IgM is present in the sample, the
DV antigen binds to the anti-DV in the well. Mouse
anti-DV conjugated with horseradish peroxidase is then
added to the wells and incubated. Enzyme substrate and
chromogen are added, and the color is allowed to develop.
After adding the Stop Reagent, the resultant color change is
quantified by a spectrophotometric reading of optical
density (OD) which is directly proportional to the amount
of antigen-specific IgM present in the sample. Sample
optical density readings are compared with reference cut--
off OD readings to determine results. An index value of >
1.00 is presumptive for the presence of IgM antibodies to
dengue virus.
IgG assay is also an indirect ELISA. The polystyrene
microwells are coated with equal proportions of inacti-
vated and purified Dengue virus types 1–4. Diluted
serum samples and controls are incubated in the wells
to allow specific antibody present in the samples to react
with the antigen. Nonspecific reactants are removed by
washing and peroxidase-conjugated anti-human IgG is
added and reacts with specific IgG. Excess conjugate is
removed by washing. Enzyme substrate and chromogen
are added, and the color is allowed to develop. After
adding the Stop Reagent, the resultant color change is
quantified by a spectrophotometric reading whose
principle is similar to the one described for IgM above.
An index value of > 1.00 is presumptive for the presence
of IgG antibodies to dengue virus.
Ratio of IgG to IgM (IgG/IgM)
This was calculated by dividing the IgG index to the
IgM index value for each sample. It is important to note
that all the data related to this calculation was made on
day 2 of the illness.
Statistics
Statistical analysis was done on an MS Windows-based PC
computer. The data were first keyed into a Microsoft Excel
spreadsheet and then analyzed by Statistical Package for the
Social Sciences (SPSS), Version 20.0, from SPSS incorpor-
ation Chicago IL. We used mean, standard deviation/stand-
ard error of mean, and percentage when appropriate for the
patient’s characteristic description. Group differences were
compared using the Pearson χ2 or Fisher’s exact test for
categorical variables, or the Student t test or the Mann–
Whitney U test for continuous variables. P-values of 0.05 or
less were considered statistically significant. Sensitivity, spe-
cificity, accuracy and likelihood ratios were determined for
different IgG/IgM ratios and the best value was determined
by looking at the combination of these parameters. Receiver
operator curves were determined for the chosen ratio and
area under the curve (AUC) determined. An AUC of more
than 0.9 is considered excellent.
Ethics
The study was approved by Ethics approval boards of
the hospitals where the study was conducted (Institute
Ethics committee of Fortis Memorial Research Institute
and Institute Ethics committee of Paras Super specialty
Hospital). Written informed consent was obtained from
all the patients involved in the study.
Results
Of the 225 patients initially recruited 114 were confirmed
by RT-PCR to be having dengue and were studied further.
Dengue serotype 1 was the most common found in 60.5%
patients (n = 69) (Fig. 1). 66.7% (76 patients) had second-
ary dengue and 33.3% (38 patients) had primary dengue.
None of the patients were found to have serotype 3.
Demographic characters, clinical features, laboratory data
and serological features are shown in Table 1. Number of
males is significantly higher than females. Secondary
dengue patients’ have a lower mean age, higher mean
maximum temperature, lower platelet counts, lower IgM
index, higher IgG index, higher Ig G/ Ig M ratio and more
chances of having DHF/DSS.
Table 2 shows the comparison for different IgG/IgM
ratios for the diagnosis of secondary dengue. A ratio of 1.10
was found to be the best for the diagnosis of secondary
dengue with a sensitivity of 100%, specificity of 97.4% and a
positive likelihood ratio of +38.46. Figure 2 shows the
receiver operator curve (ROC) for the selected ratio to be
0.987 which is an excellent measure. The same figure also
shows ROC for other ratios which were significantly lower.
Discussion
The early diagnosis of secondary dengue is important be-
cause it has been recognized as a significant risk factor for
development of severe dengue [13]. In our study, out of the
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Fig. 1 Pie Chart showing the frequencies of different Dengue virus serotypes found in our study. As can be seen Serotype 1 was the most common,
found in 60.5% (n= 69), and followed by serotype 2 (31.6%, n= 36) and serotype 4 (7.9%, n= 8). Serotype 3 was not found in any patient
Table 1 Comparison of main characters of patients of primary and secondary dengue
Characteristic Total patients Primary dengue Secondary dengue P value
N = 114 N = 38 (33.3%) N = 76 (66.7%)
Sex % (n)
Males 70.2% (80) 76.3% (29) 67.1% (51) 0.387
Females 29.8% (34) 23.7% (9) 32.9% (25)
Age (mean ± SD), Years 38.52 ± 10.99 42.18 ± 11.64 36.68 ± 10.24 0.011
Max temp. (mean ± SD), Fahrenheit 101.2 ± 1.51 100.79 ± 1.25 101.56 ± 1.558 0.015
Platelet count (mean ± SD) × 103/micl 67.16 ± 45.31 100.45 ± 38.66 50.51 ± 38.91 <0.0001
IgM index (mean ± SD) 1.21 ± 0.85 1.45 ± 1.24 1.09 ± 0.55 0.032
IgG index (mean ± SD) 2.81 ± 1.92 0.30 ± 0.14 4.06 ± 0.88 <0.0001
Ig M D2 % (N) 51.8% (59) 44.7% (17) 55.3% (42) 0.324
IgM D7 % (N) 96.5% (110) 97.4% (37) 96.1 (73) 1.0
IgG % (N) 66.7% (76) 0% 100% (76) <0.0001
IgG/ IgM (mean ± SD) 3.22 ± 2.91 0.34 ± 0.27 4.65 ± 2.53 <0.0001
Dengue fever %(n) 73.7% (84) 97.4% (37) 61.8 (47) <0.0001
DHF/DSS % (N) 26.3% (30) 2.6% (1) 38.2% (29)
NS1 % (N) 90.4% (103) 92.1% (35) 89.5% (68) 0.749
This table shows the characteristics of the patients studied and compares amongst the primary and secondary cases
Abbreviations: N number, SD standard deviation, DHF dengue hemorrhagic fever, DSS dengue shock syndrome, NS1 nonstructural protein 1 antigen, Ig M D2 IgM
done on day 2, Ig M D7 IgM done on day 7
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114 cases studied a majority was of secondary cases (66.7%
vs. 33.3%). Other studies have also reported a higher
number of secondary dengue cases [18, 19]. Higher number
of secondary dengue infections occurs only in Dengue-
endemic countries. Pathogenesis in dengue is linked to the
host immune response, which is triggered by infection with
the virus. Primary infection is usually benign. Secondary in-
fection with a different serotype or multiple infections with
different serotypes may, however, cause severe infection
[20]. This leads secondary dengue to be clinically more ap-
parent and thus more people seeking medical care. This is
further evidenced in our study by secondary dengue cases
having a higher mean maximum temperature, lower plate-
let counts and a significantly higher percentage of DHF/
DSS. We had a much higher percentage of males in the
study compared to the females (70.2% vs. 29.8%). A
few other hospital based studies from India suggest a
similar trend [21, 22]. This could be due to males
spending more time outdoors in the conservative In-
dian society or due to differential seeking of medical
care by different sexes or due to biological differences
in the sexes to dengue virus. Serotype 1 was most
common followed by 2 and 4. No DENV3 was iso-
lated. Dengue virus type-1 was the prevalent serotype
in another recently conducted study from North India
[23]. Also we found that patients with secondary den-
gue were younger than those with primary dengue.
Some other studies have reported otherwise [24].
Table 2 Different ratios of IgG/IgM for the diagnosis of
secondary dengue fever
IgG/ IgM ratio Sensitivity Specificity Accuracy LR+ LR-
2.0 86.8 100% 57.9 ∞ 0.132
1.5 94% 100% 63.2 ∞ 0.06
1.4 94.7 100.0% 63.2 ∞ 0.053
1.3 94.7 100.0% 63.2 ∞ 0.053
1.2 97.4% 97.4% 65.8 37.4 0.026
1.15 100% 97.4% 67.5 + 38.46 0
1.10a 100% 97.4% 67.5 + 38.46 0
0.9 100% 65.8% 78.1% 2.9 0
This table shows the sensitivity, specificity, accuracy, LR+ and LR- calculated
for different ratios of IgG/IgM for the diagnosis of secondary dengue fever
Abbreviations: LR+ positive likelihood ratio, LR- negative likelihood ratio
aMost useful value to diagnose secondary dengue. 1.10 is chosen as the most
accurate ratio of IgG/IgM to diagnose based on all the variables used here
∞ value cannot be ascertained
Fig. 2 Receiver operator curve for IgG/IgM ratio of 1.10. The area under the curve is 0.987. The curve is on the left extreme and is in blue. The
other red curves are for the IgG/IgM ratios of 1.2,1.3,1.5 and 2.0 respectively as we move to the diagonal line. 2.0 is closest to the diagonal line.
The curve closest to the diagonal line is considered the least accurate. A value of more than 0.9 is considered excellent
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IgM tested on day 2 was positive in 51.8% only while
it increased to 96.5% on day 7 of the illness. This result
reiterates the well accepted dictum that IgM ELISA is
the test of choice after first 5 days of Illness [25]. NS1 is
much easily detected in the first few days of dengue as
was seen in 90.4% of our cases. Mean IgM index tested
on day 2 of illness was found to be higher in primary
cases than in secondary cases. On the other side, mean
IgG index tested on day 2 was found to be almost 4
times higher in secondary dengue. Similar conclusions
have been derived in some other studies too [12, 26, 27].
Thus in early phase of dengue NS1 and PCR are better
tests for diagnosis and later IgM is better. This is true
for both primary and secondary dengue fever.
IgG/ IgM ratio has been studied in many studies for
early differentiation of primary and secondary dengue.
Ratios done at different time stages of the disease have
revealed different proposed cut offs [12, 14, 18, 28]. We
found the IgG/ IgM ratio of 1.10 and higher to be the
best cut off value for differentiating secondary from pri-
mary dengue. Ratios ranging from 1.1 to 2 have been
proposed in other studies. These differing ratios can be
due to difference in the times of collection of sera, dif-
ferences in the populations being studied and differences
in the laboratory methods studied. Cucunawangsih et al.
conducted a study in Indonesia where the ratio was
measured within 3 days of onset of disease and found
the best ratio to be 1.14. Although their laboratory
methods are very similar to ours but there sample size is
almost three times lower than ours (48 vs. 114) [18]. We
suggest that IgG/IgM ratio can eventually be used in
some settings/situations as an additional tool for pa-
tients’ screening in addition to the traditional clinical
warning signs of dengue which still are the best.
One limitation of our study is that we have not differenti-
ated between secondary, tertiary or quaternary dengue. We
have primarily differentiated primary from non-primary
dengue. We have assumed that the non-primary dengue
was secondary dengue in most cases because of the rarity
of clinically observed third and fourth infections [29, 30]
and also because of the antibodies’ having high cross-
reactivity which complicates the distinction of two or more
preceding infections.
Conclusion
We found secondary dengue to cause a more severe disease
than primary making the differentiation important. Early
on IgG/ IgM ratio can play an important role to differenti-
ate the two. We found the ratio of ≥ 1.10 on day 2 of illness
to be the best cut off for the same.
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